These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15994791)

  • 1. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
    Perez-Caballero D; Hatziioannou T; Yang A; Cowan S; Bieniasz PD
    J Virol; 2005 Jul; 79(14):8969-78. PubMed ID: 15994791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
    Perron MJ; Stremlau M; Sodroski J
    J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilized human TRIM5α protects human T cells from HIV-1 infection.
    Richardson MW; Guo L; Xin F; Yang X; Riley JL
    Mol Ther; 2014 Jun; 22(6):1084-1095. PubMed ID: 24662946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
    Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
    Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
    Li X; Song B; Xiang SH; Sodroski J
    Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
    Ohkura S; Stoye JP
    J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction.
    Lukic Z; Goff SP; Campbell EM; Arriagada G
    Retrovirology; 2013 Feb; 10():10. PubMed ID: 23369348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
    Ohkura S; Yap MW; Sheldon T; Stoye JP
    J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
    Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
    PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
    Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J
    J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
    Yap MW; Nisole S; Stoye JP
    Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
    Javanbakht H; Diaz-Griffero F; Stremlau M; Si Z; Sodroski J
    J Biol Chem; 2005 Jul; 280(29):26933-40. PubMed ID: 15897199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human immunodeficiency virus-1 and human immunodeficiency virus-2 capsid amino acid variants with human tripartite motif 5α protein SPRY domain and its association with pathogenesis.
    Ramalingam VV; Subramanian S; Fletcher GJ; Rupali P; Varghese G; Pulimood S; Jeyaseelan L; Nandagopal B; Sridharan G; Kannangai R
    Indian J Med Microbiol; 2019; 37(4):574-583. PubMed ID: 32436883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.
    Zhang J; Ge W; Zhan P; De Clercq E; Liu X
    Curr Med Chem; 2011; 18(17):2649-54. PubMed ID: 21568899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.